These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 19572690)

  • 1. Effects of substrate, protein environment, and proximal ligand mutation on compound I and compound 0 of chloroperoxidase.
    Lai W; Chen H; Cho KB; Shaik S
    J Phys Chem A; 2009 Oct; 113(43):11763-71. PubMed ID: 19572690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantum mechanical/molecular mechanical study on the mechanisms of compound I formation in the catalytic cycle of chloroperoxidase: an overview on heme enzymes.
    Chen H; Hirao H; Derat E; Schlichting I; Shaik S
    J Phys Chem B; 2008 Aug; 112(31):9490-500. PubMed ID: 18597525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound I in heme thiolate enzymes: a comparative QM/MM study.
    Cho KB; Hirao H; Chen H; Carvajal MA; Cohen S; Derat E; Thiel W; Shaik S
    J Phys Chem A; 2008 Dec; 112(50):13128-38. PubMed ID: 18850694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New features in the catalytic cycle of cytochrome P450 during the formation of compound I from compound 0.
    Kumar D; Hirao H; de Visser SP; Zheng J; Wang D; Thiel W; Shaik S
    J Phys Chem B; 2005 Oct; 109(42):19946-51. PubMed ID: 16853579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico design of a mutant of cytochrome P450 containing selenocysteine.
    Cohen S; Kumar D; Shaik S
    J Am Chem Soc; 2006 Mar; 128(8):2649-53. PubMed ID: 16492051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for two ferryl species in chloroperoxidase compound II.
    Stone KL; Hoffart LM; Behan RK; Krebs C; Green MT
    J Am Chem Soc; 2006 May; 128(18):6147-53. PubMed ID: 16669684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compound I of nitric oxide synthase: the active site protonation state.
    Cho KB; Derat E; Shaik S
    J Am Chem Soc; 2007 Mar; 129(11):3182-8. PubMed ID: 17319660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What kinds of ferryl species exist for compound II of chloroperoxidase? A dialog of theory with experiment.
    Lai W; Chen H; Shaik S
    J Phys Chem B; 2009 Jun; 113(22):7912-7. PubMed ID: 19408918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gauging the relative oxidative powers of compound I, ferric-hydroperoxide, and the ferric-hydrogen peroxide species of cytochrome P450 toward C-H hydroxylation of a radical clock substrate.
    Derat E; Kumar D; Hirao H; Shaik S
    J Am Chem Soc; 2006 Jan; 128(2):473-84. PubMed ID: 16402834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the bound substrate in nitric oxide synthase protonated or neutral and what is the active oxidant that performs substrate hydroxylation?
    de Visser SP; Tan LS
    J Am Chem Soc; 2008 Oct; 130(39):12961-74. PubMed ID: 18774806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid freeze-quench ENDOR study of chloroperoxidase compound I: the site of the radical.
    Kim SH; Perera R; Hager LP; Dawson JH; Hoffman BM
    J Am Chem Soc; 2006 May; 128(17):5598-9. PubMed ID: 16637602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principal active species of horseradish peroxidase, compound I: a hybrid quantum mechanical/molecular mechanical study.
    Derat E; Cohen S; Shaik S; Altun A; Thiel W
    J Am Chem Soc; 2005 Oct; 127(39):13611-21. PubMed ID: 16190726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How is the reactivity of cytochrome P450cam affected by Thr252X mutation? A QM/MM study for X = serine, valine, alanine, glycine.
    Altarsha M; Benighaus T; Kumar D; Thiel W
    J Am Chem Soc; 2009 Apr; 131(13):4755-63. PubMed ID: 19281168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the active species of cytochrome P450 during camphor hydroxylation? QM/MM studies of different electronic states of compound I and of reduced and oxidized iron-oxo intermediates.
    Altun A; Shaik S; Thiel W
    J Am Chem Soc; 2007 Jul; 129(29):8978-87. PubMed ID: 17595079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-state reactivity, electromerism, tautomerism, and "surprise" isomers in the formation of compound II of the enzyme horseradish peroxidase from the principal species, compound I.
    Derat E; Shaik S
    J Am Chem Soc; 2006 Jun; 128(25):8185-98. PubMed ID: 16787083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QM/MM study of mechanisms for compound I formation in the catalytic cycle of cytochrome P450cam.
    Zheng J; Wang D; Thiel W; Shaik S
    J Am Chem Soc; 2006 Oct; 128(40):13204-15. PubMed ID: 17017800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deactivation mechanisms of chloroperoxidase during biotransformations.
    Park JB; Clark DS
    Biotechnol Bioeng; 2006 Apr; 93(6):1190-5. PubMed ID: 16425305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resonance Raman spectroscopy of oxoiron(IV) porphyrin pi-cation radical and oxoiron(IV) hemes in peroxidase intermediates.
    Terner J; Palaniappan V; Gold A; Weiss R; Fitzgerald MM; Sullivan AM; Hosten CM
    J Inorg Biochem; 2006 Apr; 100(4):480-501. PubMed ID: 16513173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering cytochrome c peroxidase into cytochrome P450: a proximal effect on heme-thiolate ligation.
    Sigman JA; Pond AE; Dawson JH; Lu Y
    Biochemistry; 1999 Aug; 38(34):11122-9. PubMed ID: 10460168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation of distal residues of horseradish peroxidase: influence on substrate binding and cavity properties.
    Howes BD; Rodriguez-Lopez JN; Smith AT; Smulevich G
    Biochemistry; 1997 Feb; 36(6):1532-43. PubMed ID: 9063902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.